Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 371-380 of 969 for hematology

Edit search filters
  1. Study of bb21217 in Multiple Myeloma

    Rochester, MN

  2. A Study to Assess Safety and Effectiveness of Venetoclax in Combination With Gilteritinib in Subjects With Relapsed/Refractory Acute Myeloid Leukemia

    Rochester, MN

  3. Phase 1 Study to Evaluate MEDI4736 in Subjects With Myelodysplastic Syndrome

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. A Study of SC-006 in Subjects With Advanced Cancer

  5. Alisertib in Treating Patients With Myelofibrosis or Relapsed or Refractory Acute Megakaryoblastic Leukemia

    Rochester, MN

  6. Pembrolizumab in Treating Patients With Locally Advanced Bladder Cancer

    Eau Claire, WI, Scottsdale/Phoenix, AZ, La Crosse, WI

  7. Panobinostat in Treating Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

    Rochester, MN

  8. Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma

  9. A Study of Investigational Immunotherapy to Determine the Safety and Effectiveness of Nivolumab and Daratumumab, with or without Pomalidomide and Dexamethasone, in Patients with Relapsed/Refractory Hematologic Malignancies

    Rochester, MN

  10. A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer